Breast Cancer

Study Finds Estrogen Receptor Levels Form a Continuous Spectrum in HER2‑Negative Breast Cancer

The graded ER percentages may better predict tumor biology and outcomes than a simple positive/negative cutoff and could reshape treatment choices if validated.